eXoZymes首席执行官将于2025年10月24日在智商平等会议上发言,讨论酶技术进步和战略。 eXoZymes CEO to present at ThinkEquity conference on Oct. 24, 2025, discussing enzyme tech progress and strategy.

eXoZymes CEO将出席智商公平公司年度投资者会议,重点介绍公司的最新动态以及向机构投资者和个人投资者提供的战略方向。 eXoZymes CEO is set to present at ThinkEquity's annual investor conference, highlighting the company's latest developments and strategic direction to institutional and individual investors. 这次活动定于2025年10月24日举行,为首席执行官提供了一个平台,以讨论该公司在酶技术方面的进展及其对工业应用的潜在影响。 The event, scheduled for October 24, 2025, provides a platform for the CEO to discuss the company’s progress in enzyme technology and its potential impact on industrial applications. 公告中没有披露任何具体的财务数字或产品细节。 No specific financial figures or product details were disclosed in the announcement.